Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7 Colonic Neoplasms 6 Recurrence 4 Prostatic Neoplasms 4 Neoplasms 4 Polycythemia Vera 3 Venous Thromboembolism 2 Thrombocythemia, Essential 2 Rectal Neoplasms 2 Myocardial Infarction 2 Esophageal Neoplasms 2 Cardiovascular Diseases 2 Adenoma 2 Vascular Diseases 1 Thrombosis 1 Thrombocytopenia 1 Stomach Neoplasms 1 Primary Myelofibrosis 1 Precancerous Conditions 1 Pathologic Processes 1 Node Positive HER2 Negative Breast Cancer 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Myocardial Ischemia 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lynch syndrome I (site-specific colonic cancer) 1 Lymphoma, Follicular 1 Liver Cirrhosis 1 Ischemic Stroke 1

Interventions

Oxaliplatin 56 Capecitabine 49 Fluorouracil 37 Cisplatin 37 S 1 (combination) 23 Paclitaxel 18 Docetaxel 18 Leucovorin 16 pembrolizumab 13 Irinotecan 12 apatinib 11 titanium silicide 9 XELOX 9 Trastuzumab 9 Nivolumab 9 Hyperthermic Intraperitoneal Chemotherapy 8 Epirubicin 8 Drug Therapy 8 Tegafur 7 Radiotherapy 6 Neoadjuvant Therapy 6 gimeracil 5 Surgical Procedures, Operative 5 Gastrectomy 5 Chemotherapy, Adjuvant 5 tislelizumab 4 S-1 plus cisplatin 4 Ramucirumab 4 zolbetuximab 3 sintilimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Stomach Neoplasms × Aspirin × Clear all

NCT04214990 2024-12-27

EASTERN

National Cancer Center, Korea

Phase 3 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡